S. Rosen

发表

Evidences showing wide presence of small genomic aberrations in chronic lymphocytic leukemia

S. Wang, Ali H. Alhasan, Y. Kim, 2010, BMC Research Notes.

Novel Phenotypic Fluorescent Three-Dimensional Co-Culture Platforms for Recapitulating Tumor in vivo Progression and for Personalized Therapy

J. Mulshine, W. Stetler-Stevenson, A. Stojadinovic, 2013, Journal of Cancer.

Methods for production of monoclonal antibodies with specificity for human lung cancer cells

J. Minna, A. Gazdar, P. Bunn, 1981, In Vitro.

Monoclonal Antibodies Against Human Lung Cancer: Potential Diagnostic and Therapeutic Use

J. Minna, A. Gazdar, D. Carney, 1983 .

Heterogeneity of cell surface antigen expression of human small cell lung cancer detected by monoclonal antibodies.

J. Minna, A. Gazdar, J. Mulshine, 1986, Cancer research.

Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides: evidence of a graft-versus-tumor effect

T. Kuzel, C. Link, J. Guitart, 2000, Bone Marrow Transplantation.

Junctional specialization in estrogen-induced renal adenocarcinomas of the golden hamster.

J. Li, R. Letourneau, S. Rosen, 1975, Cancer research.

Histological differentiation of skin toxicity between cetuximab, erlotinib and panitumumab (single ErbB1) and lapatinib (dual ErbB1/2) epidermal growth factor receptor inhibitors.

D. West, M. Lacouture, J. Guitart, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Immunohistochemical Localization of the Immunodominant Differentiation Antigen Lacto-N-Fucopentaose III in Normal Adult and Fetal Tissues Utilizing Monoclonal Antibodies

J. Minna, J. Mulshine, J. Minna, 1985 .

The evolving role of Alemtuzumab in management of patients with CLL

J. Byrd, J. Gribben, P. Venugopal, 2005, Leukemia.

Gemcitabine in hematologic malignancies

C. Nabhan, V. Gandhi, N. Krett, 2001, Current opinion in oncology.

Phase II neoadjuvant clinical trial of carboplatin and eribulin in women with triple negative early-stage breast cancer (NCT01372579)

N. Hansen, W. Gradishar, A. Gutin, 2015, Breast Cancer Research and Treatment.

Cytochrome c-dependent and -independent Induction of Apoptosis in Multiple Myeloma Cells*

D. Kufe, P. Pandey, S. Kharbanda, 1997, The Journal of Biological Chemistry.

8-Chloro-cAMP Serves as a Prodrug for the RNA Directed Nucleoside Analog, 8-Chloro-Adenosine

C. M. Stellrecht, V. Gandhi, N. Krett, 2003 .

Highlights in metastatic breast cancer From the 2012 San Antonio Breast Cancer Symposium (SABCS).

S. Khan, S. Rosen, J. Roenn, 2013, Clinical advances in hematology & oncology : H&O.

Management guidelines for use of alemtuzumab in B-cell chronic lymphocytic leukemia.

J. Byrd, M. Dyer, K. Rai, 2004, Clinical lymphoma.

Cutaneous T-Cell Lymphoma: A Paradigm for Biological Therapies

T. Kuzel, C. Querfeld, J. Guitart, 2004, Leukemia & lymphoma.

Pseudo-mycosis fungoides in a patient taking clonazepam and fluoxetine.

J. Guitart, K. Gordon, P. Domer, 1996, Journal of the American Academy of Dermatology.

Recent developments and future directions in the treatment of multiple myeloma.

S. Singhal, J. Mehta, D. Pichardo, 2003, Cancer biotherapy & radiopharmaceuticals.

Pilot neoadjuvant trial in HER2 positive breast cancer with combination of nab-paclitaxel and lapatinib

N. Hansen, D. Scholtens, W. Gradishar, 2012, Breast Cancer Research and Treatment.

A Phase I Trial of a Pegylated Liposomal Anthracycline (DoxilTM) and Lapatinib Combination in the Treatment of Metastatic Breast Cancer: Dose-Escalation Results of an Anthracycline and Lapatinib Combination Trial.

A. Rademaker, W. Gradishar, S. Rubin, 2009 .

Preliminary Report of a Phase 1 Study of CMC-544, an Antibody-Targeted Chemotherapy Agent, in Patients with B-Cell Non-Hodgkin’s Lymphoma (NHL).

E. Giné, A. Rohatiner, C. Gisselbrecht, 2005 .

Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapy.

Sonali M. Smith, C. Flowers, B. Woda, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Monoclonal antibodies that demonstrate specificity for several types of human lung cancer.

J. Minna, A. Gazdar, S. Rosen, 1981, Proceedings of the National Academy of Sciences of the United States of America.

Long-term persistence of human anti-murine antibody responses following radioimmunodetection and radioimmunotherapy of cutaneous T-cell lymphoma patients using 131I-T101.

A. M. Zimmer, S. Rosen, L. Manzel, 1988, Experimental hematology.

Radioimmunotherapy of patients with cutaneous T-cell lymphoma using an iodine-131-labeled monoclonal antibody: analysis of retreatment following plasmapheresis.

E. A. Silverstein, R. Goldman-Leikin, J. Kazikiewicz, 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Mycosis fungoides and the Sézary syndrome: a review of pathogenesis, diagnosis, and therapy.

T. Kuzel, S. Rosen, S. Rosen, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pilot Neoadjuvant Trial with Combination of Lapatinib and Nab-Paclitaxel in HER2+ Breast Cancer.

N. Hansen, W. Gradishar, J. Jeruss, 2009 .